Stay Informed. Stay Ahead.

Every month, our team of PhDs, engineers, and oncology experts distills the rapidly evolving oncology landscape into a single, structured report. Organized by tumor type and area of focus, each issue provides a clear, evidence-based overview of the developments that matter most.

We continuously monitor FDA announcements, peer-reviewed publications, clinical trial updates, industry movements, conference data, and upcoming regulatory milestones. Our AI systems surface the most relevant insights, and our expert team reviews and refines them to ensure accuracy, context, and clinical relevance.

With OncRef’s Monthly Newsletter, you can confidently keep pace with the latest advances and use our report as a trusted reference across your oncology work.

Each issue includes:

• Key Highlights: A high-level summary of the month’s most important developments.
• Industry Regulatory & Pipeline Updates: IND submissions, NDA/ BLA filings, PDUFA dates, topline readouts from pivotal trials, and newly approved therapies.
• Conference Coverage: Summaries of abstracts, presentations, and sessions relevant to your specialty.
• Publication Insights: Key findings from new peer-reviewed studies on approved and emerging therapies.
• Clinical Trial Intelligence: Newly registered studies and trials approaching primary completion in your areas of interest.